fbpx

FORGOT YOUR DETAILS?

Adimarket Named as Distributor for Innovative GCell Micrograft Technology The partnership between Adimarket and Global Medical Group delivers an FDA-compliant stem cells procedure to physicians practicing regenerative medicine across the globe MIAMI LAKES, Florida—Adimarket, LLC, a subsidiary of the Global Stem Cells Group (GSCG), has entered an agreement with Global Medical Group (GMG) to distribute

Cellgenic Flow Exosomes has a wide range of therapeutic implications, including hair loss and pain management MIAMI LAKES, Florida—The Global Stem Cells Group (GSCG) has announced the release of a new product in response to growing demands from regenerative medicine practitioners for cellular products derived from birth tissue. The product, Cellgenic Flow Exosomes, is 100%

With video lectures and additional tools from some of the most respected names in today’s stem cells field, the course arms practitioners with the necessary knowledge and resources to offer innovative regenerative medicine treatments in their existing practices MIAMI LAKES, Florida— The International Society for Stem Cell Application (ISSCA) (www.issca.us) has announced it has launched

Miami Lakes Award Program Honors the Achievement MIAMI LAKES November 14, 2019 — Global Stem Cells Group has been selected for the 2019 Best of Miami Lakes Award in the Biotechnology Company category by the Miami Lakes Award Program. Each year, the Miami Lakes Award Program identifies companies that we believe have achieved exceptional marketing

The awards recognize the physicians’ leadership in education and instruction in regenerative medicine MIAMI LAKES, Florida—Three faculty members with the International Society for Stem Cell Application (ISSCA) were honored with awards at the organization’s recent regenerative medicine conference held at the University of Miami on October 24-27. The awards were sponsored by the Sociedad Internacional

The organization seeks to improve education and access to stem cells therapies for physicians and patients worldwideThe organization seeks to improve education and access to stem cells therapies for physicians and patients worldwide MIAMI LAKES, Florida—Following two recent highly successful conferences, the International Society for Stem Cell Application (ISSCA) is set to offer six additional

The regenerative medicine symposium was held on October 24-27 with nearly 200 attendees and over 20 expert speakers MIAMI LAKES, Florida—The International Society for Stem Cell Application (ISSCA), in collaboration with SISDET, held a highly successful three-day medical conference on the University of Miami campus on October 24-26. The conference featured a host of international

The courses will target physicians based in the Americas, providing them with critical stem cells education and tools needed to implement protocols in their own practices The International Society for Stem Cell Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and regenerative medicine,

The ISSCA sponsored symposium is in its sixth year, sharing recent advancements in stem cells therapies with physicians looking to implement them into their own practices The International Society for Stem Cell Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and regenerative medicine,

The certification will target physicians in the Middle East and Europe, providing them with critical education to implement stem cells treatments in their own practices The International Society for Stem Cell Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and regenerative medicine, is

The subsidiary of the Global Stem Cells Group seeks to meet the growing demand for patients seeking stem cells treatments across the globe. MIAMI LAKES, Florida— Cellgenic, a subsidiary of the Global Stem Cells Group (GSCG), has announced that it has signed an agreement that will bring regenerative medical treatments to more patients across Europe

MIAMI LAKES, Florida—The Global Stem Cells Group (GSCG), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and regenerative medicine, announced its participation in a new clinical trial in Miami. The trial is sponsored by InGeneron, Inc. and will provide researchers the opportunity to compare two

TOP